| Literature DB >> 31510025 |
Alessandro Arrigo1, Francesco Romano2, Giorgia Albertini3, Emanuela Aragona4, Francesco Bandello5, Maurizio Battaglia Parodi6.
Abstract
BACKGROUND: Retinitis Pigmentosa (RP) represents a retinal dystrophy with an extremely complex pathogenesis further worsened by the impairment of the retinal vascular supply. The main goal of this study was to identify different vascular patterns in RP, by means of optical coherence tomography angiography (OCTA).Entities:
Keywords: OCT; OCTA; Retinitis Pigmentosa; vessel density; vessel dispersion; vessel rarefaction; vessel tortuosity
Year: 2019 PMID: 31510025 PMCID: PMC6780333 DOI: 10.3390/jcm8091425
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Optical coherence tomography angiography (OCTA) quantitative analyses pipeline. Extensive description is provided in the methods section.
Demographic features of RP patients and healthy controls.
| Demographic and Clinical Features | ||
|---|---|---|
| Parameter | Retinitis Pigmentosa Patients | Controls |
| Sex (M/F) | 16/16 | 16/16 |
| Age | 43.2 ± 12.5 | 42.8 ± 11.2 |
| BCVA | 0.21 ± 0.34 | 0.0 ± 0.0 |
| CMT | 231.49 ± 28.22 | 301.52 ± 18.55 |
| CT | 214.31 ± 41.03 | 255.85 ± 25.79 |
| RNFL | 82.53 ± 19.77 | 101.21 ± 9.15 |
The following abbreviations are used: best corrected visual acuity (BCVA), central macular thickness (CMT), choroidal thickness (CT), and retinal nerve fiber layer (RNFL).
Genetic analysis in Retinitis Pigmentosa.
| Genetic Analysis in Retinitis Pigmentosa | ||
|---|---|---|
| Gene | Number of Patients | % |
|
| 6 | 18.75 |
|
| 8 | 25 |
|
| 3 | 9.375 |
|
| 2 | 6.25 |
|
| 1 | 3.125 |
|
| 1 | 3.125 |
|
| 1 | 3.125 |
|
| 1 | 3.125 |
|
| 1 | 3.125 |
|
| 1 | 3.125 |
|
| 1 | 3.125 |
|
| 1 | 3.125 |
|
| 1 | 3.125 |
|
| 1 | 3.125 |
|
| 1 | 3.125 |
|
| 1 | 3.125 |
|
| 1 | 3.125 |
Figure 2Optic nerve head OCTA in Retinitis Pigmentosa (RP). OCTA reconstructions are shown as follows: superficial capillary plexus (SCP) (A), deep capillary plexus (DCP) (B), radial peripapillary capillaries (RPCs) (C), and choriocapillary (CC) (D) for a specimen RP patient and the same plexa for a control subject (E–H). SCP and CC appeared almost preserved compared with a healthy eye. On the contrary, DCP and RPCs appeared strongly altered in RP. In particular, both not perfused and rarefied regions can be easily qualitatively distinguished.
The most relevant OCTA parameters of RP patients and healthy controls.
| OCTA Parameters in Retinitis Pigmentosa | ||||||
|---|---|---|---|---|---|---|
|
| ||||||
| Vascular Plexus | mSCP | mDCP | mCC | |||
| RP | 0.39 ± 0.02 | 0.36 ± 0.03 | 0.49 ± 0.01 | |||
| Controls | 0.41 ± 0.01 | 0.43 ± 0.01 | 0.50 ± 0.01 | |||
|
| ||||||
| Vascular Plexus | mSCP | mDCP | ||||
| RP Patients | 24 ± 15 | 16 ± 12 | ||||
| Controls | 11 ± 4 | 11 ± 3 | ||||
|
| ||||||
| Vascular Plexus | mSCP | mDCP | ||||
| RP Patients | 4.80 ± 0.29 | 4.42 ± 0.49 | ||||
| Controls | 7.20 ± 0.31 | 7.84 ± 0.34 | ||||
|
| ||||||
| Vascular Plexus | mSCP | mDCP | ||||
| RP Patients | 0.66 ± 0.04 | 0.62 ± 0.03 | ||||
| Controls | 1.80 ± 0.32 | 1.09 ± 0.20 | ||||
The following abbreviations are used: macular superficial capillary plexa (mSCP), macular deep capillary plexus (mDCP), macular choriocapillary (mCC). Extensive data are provided in Table S1.
Correlation analysis of quantitative parameters. Only the most relevant statistically significant correlations are reported. Complete data are provided in Table S2. Vessel density (VD), vessel tortuosity (VT), vessel dispersion (VDisp), and vessel rarefaction (VR).
| Correlation Analysis | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VD Mean | Vdisp Mean | |||||||||||||
| AGE | Tau Coeff. | −0.282 | 0.286 | |||||||||||
| 0.02 | 0.02 | |||||||||||||
| CMT | BCVA (logMAR) | VD mSCP | VD mDCP | VD mCC | VD Mean | Vdisp Mean | VT mSCP | VT mDCP | VT Mean | VR mSCP | VR mDCP | VR Mean | ||
| RNFL | Tau Coeff. | 0.375 | −0.548 | 0.529 | 0.255 | 0.44 | 0.578 | −0.368 | 0.287 | 0.376 | 0.448 | −0.392 | −0.396 | −0.481 |
| <0.01 | <0.01 | <0.01 | 0.04 | <0.01 | <0.01 | <0.01 | 0.02 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | ||
| BCVA (logMAR) | VD mSCP | VD mDCP | VD mCC | VD Mean | Vdisp mDCP | Vdisp Mean | VT mSCP | VT mDCP | VT Mean | VR mSCP | VR mDCP | VR Mean | ||
| CMT | Tau Coeff. | −0.673 | 0.52 | 0.313 | 0.516 | 0.479 | −0.451 | −0.447 | 0.568 | 0.354 | 0.576 | −0.564 | −0.601 | −0.625 |
| <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | ||
| VD mSCP | VD mDCP | VD mCC | VD Mean | Vdisp mDCP | Vdisp Mean | VT mSCP | VT mDCP | VT Mean | VR mSCP | VR mDCP | VR Mean | |||
| BCVA (logMAR) | Tau Coeff. | −0.443 | −0.463 | −0.592 | −0.573 | 0.563 | 0.563 | −0.621 | −0.463 | −0.712 | 0.645 | 0.573 | 0.721 | |
| <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | |||
Cut-off analysis in Retinitis Pigmentosa.
| OCTA Cut-off Analysis | ||||
|---|---|---|---|---|
| Parameter | Mean ± STD | |||
| RNFL | RP1 | 96 ± 10 | RP1 vs. RP2 | <0.01 |
| RP2 | 62 ± 10 | RP1 vs. Controls | 0.286 | |
| Controls | 101 ± 9 | RP2 vs. Controls | <0.01 | |
| CMT | RP1 | 247 ± 21 | RP1 vs. RP2 | <0.01 |
| RP2 | 209 ± 23 | RP1 vs. Controls | <0.01 | |
| Controls | 302 ± 19 | RP2 vs. Controls | <0.01 | |
| BCVA (logMAR) | RP1 | 0.01 ± 0.04 | RP1 vs. RP2 | <0.01 |
| RP2 | 0.49 ± 0.38 | RP1 vs. Controls | 0.94 | |
| Controls | 0 ± 0 | RP2 vs. Controls | <0.01 | |
| VD mSCP | RP1 | 0.41 ± 0.02 | RP1 vs. RP2 | <0.01 |
| RP2 | 0.38 ± 0.01 | RP1 vs. Controls | 0.976 | |
| Controls | 0.41 ± 0.01 | RP2 vs. Controls | <0.01 | |
| VD mDCP | RP1 | 0.37 ± 0.03 | RP1 vs. RP2 | <0.01 |
| RP2 | 0.35 ± 0.02 | RP1 vs. Controls | <0.01 | |
| Controls | 0.43 ± 0.01 | RP2 vs. Controls | <0.01 | |
| VD mCC | RP1 | 0.50 ± 0.02 | RP1 vs. RP2 | <0.01 |
| RP2 | 0.47 ± 0.01 | RP1 vs. Controls | 0.768 | |
| Controls | 0.50 ± 0.01 | RP2 vs. Controls | <0.01 | |
| Vdisp mSCP | RP1 | 12.76 ± 3.71 | RP1 vs. RP2 | <0.01 |
| RP2 | 21.42 ± 15.77 | RP1 vs. Controls | 0.92 | |
| Controls | 10.72 ± 4.15 | RP2 vs. Controls | <0.01 | |
| Vdisp mDCP | RP1 | 13.66 ± 4.51 | RP1 vs. RP2 | <0.01 |
| RP2 | 34.75 ± 9.43 | RP1 vs. Controls | 0.53 | |
| Controls | 11.45 ± 3.48 | RP2 vs. Controls | <0.01 | |
| VT mSCP | RP1 | 5.16 ± 0.34 | RP1 vs. RP2 | <0.01 |
| RP2 | 4.56 ± 0.15 | RP1 vs. Controls | <0.01 | |
| Controls | 7.20 ± 0.31 | RP2 vs. Controls | <0.01 | |
| VT mDCP | RP1 | 4.86 ± 0.29 | RP1 vs. RP2 | <0.01 |
| RP2 | 4.23 ± 0.35 | RP1 vs. Controls | <0.01 | |
| Controls | 7.84 ± 0.34 | RP2 vs. Controls | <0.01 | |
| VR mSCP | RP1 | 0.62 ± 0.03 | RP1 vs. RP2 | <0.01 |
| RP2 | 0.70 ± 0.02 | RP1 vs. Controls | <0.01 | |
| Controls | 0.41 ± 0.01 | RP2 vs. Controls | <0.01 | |
| VR mDCP | RP1 | 0.59 ± 0.03 | RP1 vs. RP2 | <0.01 |
| RP2 | 0.65 ± 0.02 | RP1 vs. Controls | <0.01 | |
| Controls | 0.43 ± 0.01 | RP2 vs. Controls | <0.01 | |
Retinitis Pigmentosa (RP)1 was defined with mean VT > 4.80 and mean VR < 0.62, whereas RP2 was defined with mean VT < 4.80 and mean VR > 0.62. Only the most relevant data are reported. Complete data are extensively shown in Table S3. Central macular thickness (CMT) and retinal nerve fiber layer (RNFL).